D014568Chemicals & DrugsD08.811.277.656.300.760.910D08.811.277.656.959.350.910D12.776.124.125.662.884550.997657Urokinase-Type Plasminogen ActivatorFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.1869160.01209745research area of0.7665370.033507211subject area forMehmetAltintasMehmet Altintas349147Altintas, MehmetAssociate ProfessorAnnabelleVolgmanAnnabelle Volgman349709Volgman, AnnabelleProfessorChangli (David)WeiChangli (David) Wei349720Wei, Changli (David)Associate Professor5Associate Professor4Professor31995687Hayek SS, Leaf DE, Samman Tahhan A, Raad M, Sharma S, Waikar SS, Sever S, Camacho A, Wang X, Dande RR, Ibrahim NE, Baron RM, Altintas MM, Wei C, Sheikh-Hamad D, Pan JS, Holliday MW, Januzzi JL, Weisbord SD, Quyyumi AA, Reiser JThe New England journal of medicineSoluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426.N Engl J Med2020-01-30T00:00:002020Soluble Urokinase Receptor and Acute Kidney Injury.32459936Hayek SS, Leaf DE, Reiser JThe New England journal of medicineSoluble Urokinase Receptor and Acute Kidney Injury. Reply. N Engl J Med. 2020 05 28; 382(22):2167-2168.N Engl J Med2020-05-28T00:00:002020Soluble Urokinase Receptor and Acute Kidney Injury. Reply.true1Associate ProfessorAssociate ProfessorAlexandreD'AudiffretAlexandre D'Audiffret350096D'Audiffret, AlexandreAssociate ProfessorNeurological SciencesRush University, Rush Medical CollegeDavidBennettDavid A. Bennett41.87328300000000-87.66936330000000349004Bennett, DavidProfessor35185364Morath C, Hayek SS, D?hler B, Nusshag C, Sommerer C, Zeier M, Reiser J, S?sal CTransplant international : official journal of the European Society for Organ TransplantationSoluble Urokinase Receptor and Mortality in Kidney Transplant Recipients. Transpl Int. 2021; 35:10071.Transpl Int2022-02-03T00:00:002022Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients.Cardiovascular and Thoracic Surgerytrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorInternal Medicine, Division of CardiologyInternal Medicine, Division of Nephrology36194491Hindy G, Tyrrell DJ, Vasbinder A, Wei C, Presswalla F, Wang H, Blakely P, Ozel AB, Graham S, Holton GH, Dowsett J, Fahed AC, Amadi KM, Erne GK, Tekmulla A, Ismail A, Launius C, Sotoodehnia N, Pankow JS, Th?rner LW, Erikstrup C, Pedersen OB, Banasik K, Brunak S, Ullum H, Eugen-Olsen J, Ostrowski SRThe Journal of clinical investigationIncreased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis. J Clin Invest. 2022 12 15; 132(24).J Clin Invest2022-12-15T00:00:002022Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.35924778Luo S, Vasbinder A, Du-Fay-de-Lavallaz JM, Gomez JMD, Suboc T, Anderson E, Tekumulla A, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O'Hayer P, Catalan T, Blakely P, Launius C, Amadi KM, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Altintas I, Eugen-Olsen J, Williams KA, Volgman AS, Reiser J, Hayek SSJournal of the American Heart AssociationSoluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc. 2022 09 20; 11(18):e025198.J Am Heart Assoc2022-08-04T00:00:002022Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.